This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Emcure Pharmaceuticals Emcure Pharmaceuticals Limited’s stock, with a market capitalisation of Rs. According to CNBC-TV18, BC Investments IV, backed by Bain Capital, is planning to sell a 2.4% As of March 2025 , BC Investments IV held an 8.68% stake in Emcure Pharmaceuticals. 23,762 crores, fell to Rs. 1,771 crore.
Though the industry is capital-intensive, the rewards can be gigantic with the right plan and timing. Healthcare & Pharmaceuticals Though never in the limelight, healthcare is a lucrative and essential industry. Here, billionaires are often pharmaceutical firms, healthcare device makers, or chains of hospitals.
Breakthroughs like GLP-1 drugs are already shifting how the market views pharmaceutical stocks. IBM has announced that it plans to invest $150 billion in the U.S. So, if you are planning your next investment move, speak to a financial advisor about the future of AI and other tech enhancements.
Alongside these, several other companies like CRISIL, Hawkins Cookers, United Spirits, Alembic Pharmaceuticals, Taparia Tools, Data Patterns (India), and Apar Industries will also trade ex-dividend. 900% Alembic Pharmaceuticals Ltd 29 Jul 2025 ₹11.00 Dividends are attractive, but smart investing requires careful planning and analysis.
Tell us what, what the career plans were. We’re serving family offices, we’re serving institutions, we’ve done acquisitions in, in the stock plan businesses, in the retirement businesses. Let’s assume that we are administering a stock plan for a large corporate client. Lisa Shalett : Not at all.
What was the career plan? 00:01:42 [Speaker Changed] The career plan originally was urban development and transportation. So that’s when I really studied deeply the research why what I’d been doing was working more about when it might not and writing a business plan for Bridgeway. It was 150% of our net worth.
According to sources, foreign investor OrbiMed Asia IV Mauritius FVCI Limited planned to offload a 2.27 Marksans Pharma Limited is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. Marksans Pharma Limited With a market cap of Rs. crores, the stock moved up by nearly 7.5
With its new clinical trial now underway, United Therapeutics is planning to transplant up to 50 patients with modified pig kidneys in the coming months. Here is a more detailed description of the drivers: New Markets for Core Drugs : Any biotech or pharmaceutical company is in the business of searching for new markets to sell its products.
The fifth round of talks wrapped up without any agreement, and while both parties plan to continue negotiations in mid-August, it seems unlikely that an interim deal will be reached before the August 1 deadline. As the EU prepares counter-tariffs amounting to €93 billion, industries like automotive, pharmaceuticals, and wine are at risk.
Dollenmeyer, Megan Vandermeer Aug 13, 2025 9 Min Read Business Planning Related Topics Client Relations Growth Strategies Professional Development Diversity & Inclusion Recent in Business Planning See All Businessman hand holding magnet and magnetizing avatars. and West Pharmaceutical Services Inc.,
Simply put, its chaos, and its hard for businesses to plan around any of this. Perhaps the 25% steel and aluminum tariffs also remain, but we don’t see other large sectoral tariffs, such as the 25% on autos, chips, electronics, and pharmaceuticals. higher on the day. Do you keep hiring? Do you let people go to raise cashflow?
Stock to Watch Alembic Pharmaceuticals: Alembic Pharma received final USFDA approval for its Carbamazepine extended-release tablets, used for seizures and nerve pain with a $71 million US market. JSW Energy: JSW Energy was allowed by the NCLT to withdraw insolvency proceedings for KSK Water and will now implement its settlement plan.
It has 26 million square feet of current projects in addition to 16 million square feet of planned launches. The business has a sizable pipeline of about 16 million square feet of residential, commercial, and hospitality developments planned for the next fiscal year. It started 11.5 points, or 0.68%.
Also Read: Pharma stock in focus after receiving ₹6 Cr order to supply pharmaceutical products Company Profile Kernex Microsystems (India) Ltd specializes in delivering high-quality electronic systems that can perform well even in tough environmental conditions. Kernex Microsystems (India) Ltd has a strong total order book worth Rs.
The following stocks have recently formed a Death Crossover pattern Caplin Point Laboratories Ltd Caplin Point is a rapidly growing pharmaceutical company with a strong presence in Latin America and Africa, as well as plans to expand in the United States and the European Union.
nadig.com) Why you may start seeing crypto show up in 401(k) plans. tomtunguz.com) Pharmaceuticals HHS has cancelled funding for a Moderna ($MRNA) mRNA vaccine for bird flu. (morningstar.com) The evidence on active fund manager performance is woeful. ritholtz.com) Fund management Who said ETF innovation is dead?
is an engineering and construction company that specializes in turnkey EPC (Engineering, Procurement, and Construction) projects across various sectors, including industrial, commercial, institutional, pharmaceutical, and renewable energy. Sathlokhar Synergys E&C Global Sathlokhar Synergys E&C Global Ltd.
Synopsis: Stocks like Sona BLW, Endurance Technologies, Exide Industries, PG Electroplast, etc, are in focus after sources indicate that the Government is eyeing to deploy a 13,000 crore package in two incentive plans. Even Kopran Ltd.,
India’s pharmaceutical sector is a global powerhouse, ranking third in production volume and supplying 20% of the world’s generic medicines. Nifty Pharma declined by 416 points (1.81%) to 21,639.85, following reports that US President Donald Trump plans to impose pharma tariffs soon. Instead, Trump hinted at a larger plan.
EU Tariff Uncertainty – There’s confusion over whether pharmaceutical products will face 15% U.S. Sensex also ended the session at 81,337.95, gaining 446.93 points or 0.55%. Global Markets Pharma Industry Seeks Clarity on U.S.-EU tariffs under the new U.S.-EU EU trade truce. Section 232 investigation, with a decision expected by August.
Affordable Entry Point: There are emerging micro-markets with planned developments that provide high upside potential and are starting to attract the interest of investors. Hyderabad – The Technology and Pharmaceutical Hub Hyderabad allows for affordability while offering good price appreciation potential.
The company plans to execute these orders in multiple tranches, based on its internal capabilities, procurement timelines, and the delivery timelines set by clients. Murae Organisor Limited, formerly known as Earum Pharmaceuticals Limited, is primarily involved in the pharmaceutical sector. The first batch, valued at around Rs.
Also Read: Microcap stock jumps 5% after Panasonic plans to acquire 55% stake in the company Strategic investment and MoU’s Along with its Q1 results, Punjab Chemicals and Crop Protection Ltd announced the signing of 3 Memorandums of Understanding (MoUs) with international customers for high value agrochemical products and intermediates.
This small-cap Pharma Stock, engaged in manufacturing and marketing pharmaceutical formulations and APIs, serving regulated and emerging markets with a focus on quality, compliance, and innovation, is in focus after management expected 50% growth in revenue and 100% growth in net profit for FY26. With a market capitalization of Rs.
formerly Suven Pharmaceuticals) has unveiled two strategic investments aimed at strengthening its presence in high-growth therapeutic modalities USD 10 million for cGMP bioconjugation expansion at its U.S. formerly Suven Pharmaceuticals) has announced two major capacity expansion projects. Synopsis : Cohance Lifesciences Ltd.
Expansion plans include doubling carbon black capacity and setting up a coal tar derivatives plant. Looking ahead, the management plans to more than double its speciality carbon black production capacity. Synopsis : Himadri Speciality Chemical reported Rs. 1,118 crore revenue and Rs. 179 crore net profit in Q1 FY26.
Rapid urbanization and improper planning causes water logging problems and inadequate public services. Hyderabad Projected Metro Population (2025): 11, 338, 000 Trend of growth: +2.43% from 2024 The demographic explosion of Hyderabad is a revealer: Pharma and IT: Great centers of pharmaceutical R&D and software services.
Graphite India : Plans to expand its graphite electrodes capacity by 25,000 TPA over the next 3 years. 5.1%) GlaxoSmithKline Pharmaceuticals Ltd. Safari Industries: Posted a strong Q1, with net profit at ₹50.5 crore, revenue at ₹530 crore, and EBITDA at ₹79.3 Margins improved to 15% from 14.64% YoY. 7.1%) PNB Housing Finance Ltd.
During Friday’s trading session, shares of a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products surged by around 1 percent on the BSE to Rs. Further, Senores Pharma plans to launch 31 ANDAs and 23 CDMO/CMO products in regulated markets for FY26.
percent, pharmaceuticals (Rs. For FY26, the company has planned an indicative capital expenditure of around Rs. It is diversified across various sectors, with oil & gas (Rs. crore) contributing 8.6 percent and nuclear power (Rs. 49 crore) at 12.6 Additionally, the company also received orders from chemical (Rs. crore) at 14.9
politico.com) Pharmaceuticals Do GLP-1 agonists users lose more muscle than people who lose weight in other ways? eater.com) Sports Fanatics has no plans to go public any time soon. (arstechnica.com) So much for a promising HIV vaccine candidate. npr.org) Health policy The head of HHS is a 'wilful purveyor of medical disinformation.'
India is emerging as a major player in the pharmaceutical industry, particularly in developing cancer drugs. This growth creates immense opportunities for pharmaceutical companies specializing in oncology treatments. Future Outlook Beta Drugs plans to broaden its product portfolio as it is planning to launch 25 new products by 2026.
A highlight of the future plans of the company and a summary conclude the article at the end. Additionally, it also develops prebiotics and formulations among other products for the pharmaceutical industry. Future Plans of Tata Chemicals So far we looked at the previous fiscals’ data for our fundamental analysis of Tata Chemicals.
Lastly, a highlight of their future plans and a summary conclude the article. FY 2022-23 Annual Report Its chemicals find their end applications in a multitude of industries including petrochemicals, rubber, agrochemicals, paper, pharmaceuticals, detergents, and more. Which of the two do you hold or plan to buy in the near future?
A highlight of the future plans of both the companies and a summary conclude the article at the end. Because of their different properties, fluorochemicals (or fluorine) are used in a variety of industries such as refrigeration, dyeing, automotive, pharmaceuticals, agrochemicals, textiles, electricals & electronics and more.
A highlight of the future plans and a summary conclude the article at the end. Businesses from various industries including pharmaceuticals, inks & coatings, printing & packaging, agrochemicals, adhesives, dyes & pigments, electronic, automotive, and paints make use of the products of Laxmi Organic Industries.
A highlight of the future plans and a summary conclude the article at the end. The company supplies its products to a broad range of customers from different industries including pharmaceuticals, agrochemicals, mining, FMCG, advertising, electronics, manufacturing, automotive, and more. Company Overview SRF Ltd. 70,500 EPS ₹74.4
It produces and supplies specialty pharmaceutical and healthcare ingredients and intermediates, such as contrast media intermediates and high-intensity sweeteners. Industry Overview The global pharmaceutical market, valued at US$1,381.54 In fact, 81% of its revenue is generated from its top ten customers.
Some notable pharmaceutical companies have made their way to the Nifty Index and we’re going to perform a fundamental analysis of Divis Laboratories. Overview: Indian Pharmaceutical Industry When you consume medicine for certain ailments and diseases, you’re recommended by your doctor to consume it for its curing effect.
Fundamental Analysis Of Aarti Industries : Specialty chemicals have become essential in various industries ranging from pharmaceuticals, electronics, agriculture, and automotive. The article concludes with a highlight of future plans and a summary. Let us now explore what plans the company has for the future.
in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical Industries Ltd. Shares of Axsome Therapeutics Inc. AXSM tumbled about 10.0% TEVA is seeking approval from the Food and Drug Administration to market a generic version of Auvelity, Axsome’s depression treatment. Axsome’s stock has gained 95.8%
According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. The roots of India’s pharmaceutical capabilities lay deep within its rich history. It is the 3 rd largest pharmaceutical company in India as well as the private pharmaceutical market of South Africa.
Shares of Phathom Pharmaceuticals Inc. Phathom said it plans to meet with the FDA in the first quarter of this year to discuss resubmitting vonoprazan. The company’s stock is down 38.4% over the past year, while the broader S&P 500 SPX has declined 9.5%. Visit MarketWatch.com for more information on this news.
Fundamental Analysis of Glenmark Life Sciences: For some time now, Glenmark Life Sciences, a listed subsidiary of Glenmark Pharmaceuticals has been in the news. A highlight of the R&D spending, future plans and a summary conclude the article at the end. GPL) set up its active pharmaceutical ingredient (API) business.
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content